Swiss National Bank Blueprint Medicines Corp Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Swiss National Bank holds 116,200 shares of BPMC stock, worth $13.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

116,200

Previous 114,400 1.57%

Holding current value

$13.3 Million

Previous $12.3 Million 12.87%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$84.1 - $120.5 $151,380 - $216,900	1,800 Added 1.57%	116,200 $10.7 Million
Q2 2024 Aug 08, 2024	BUY	$85.18 - $108.78 $34,072 - $43,512	400 Added 0.35%	114,400 $12.3 Million
Q1 2024 May 07, 2024	BUY	$73.17 - $99.79 $36,585 - $49,895	500 Added 0.44%	114,000 $10.8 Million
Q4 2023 Feb 06, 2024	SELL	$43.96 - $92.84 $852,824 - $1.8 Million	-19,400 Reduced 14.6%	113,500 $10.5 Million
Q3 2023 Nov 08, 2023	BUY	$46.9 - $66.0 $107,870 - $151,800	2,300 Added 1.76%	132,900 $6.67 Million
Q2 2023 Aug 09, 2023	BUY	$42.2 - $66.37 $63,300 - $99,555	1,500 Added 1.16%	130,600 $8.25 Million
Q1 2023 May 10, 2023	SELL	$37.97 - $50.0 $573,347 - $755,000	-15,100 Reduced 10.47%	129,100 $5.81 Million
Q4 2022 Feb 08, 2023	BUY	$41.06 - $66.48 $119,074 - $192,792	2,900 Added 2.05%	144,200 $6.32 Million
Q3 2022 Nov 09, 2022	BUY	$49.93 - $77.7 $89,874 - $139,860	1,800 Added 1.29%	141,300 $9.31 Million
Q2 2022 Aug 09, 2022	BUY	$45.23 - $70.15 $334,702 - $519,110	7,400 Added 5.6%	139,500 $7.05 Million
Q1 2022 May 09, 2022	BUY	$54.1 - $110.08 $519,360 - $1.06 Million	9,600 Added 7.84%	132,100 $8.44 Million
Q3 2021 Nov 08, 2021	BUY	$80.98 - $109.47 $89,078 - $120,417	1,100 Added 0.91%	122,500 $12.6 Million
Q2 2021 Aug 06, 2021	BUY	$82.78 - $101.0 $33,112 - $40,400	400 Added 0.33%	121,400 $10.7 Million
Q1 2021 May 07, 2021	BUY	$90.71 - $108.28 $208,633 - $249,044	2,300 Added 1.94%	121,000 $11.8 Million
Q4 2020 Feb 05, 2021	BUY	$92.08 - $124.48 $184,160 - $248,960	2,000 Added 1.71%	118,700 $13.3 Million
Q3 2020 Nov 09, 2020	BUY	$66.45 - $92.7 $139,545 - $194,670	2,100 Added 1.83%	116,700 $10.8 Million
Q2 2020 Aug 05, 2020	BUY	$57.09 - $79.27 $1.36 Million - $1.89 Million	23,900 Added 26.35%	114,600 $8.94 Million
Q1 2020 May 08, 2020	BUY	$48.11 - $82.22 $67,354 - $115,108	1,400 Added 1.57%	90,700 $5.3 Million
Q4 2019 Feb 06, 2020	BUY	$66.73 - $82.59 $126,787 - $156,921	1,900 Added 2.17%	89,300 $7.15 Million
Q3 2019 Nov 12, 2019	BUY	$72.9 - $101.41 $685,260 - $953,254	9,400 Added 12.05%	87,400 $6.42 Million
Q2 2019 Aug 02, 2019	BUY	$73.54 - $97.8 $360,346 - $479,220	4,900 Added 6.7%	78,000 $7.36 Million
Q1 2019 May 10, 2019	BUY	$48.7 - $86.6 $160,710 - $285,780	3,300 Added 4.73%	73,100 $5.85 Million
Q4 2018 Feb 13, 2019	BUY	$45.57 - $74.26 $59,241 - $96,538	1,300 Added 1.9%	69,800 $3.76 Million
Q2 2018 Aug 09, 2018	BUY	$60.96 - $101.18 $79,248 - $131,534	1,300 Added 1.93%	68,500 $4.35 Million
Q1 2018 May 04, 2018	BUY	$73.28 - $102.95 $183,200 - $257,375	2,500 Added 3.86%	67,200 $6.16 Million
Q4 2017 Feb 07, 2018	BUY	$62.91 - $88.32 $849,285 - $1.19 Million	13,500 Added 26.37%	64,700 $4.88 Million
Q3 2017 Nov 03, 2017	BUY	$42.37 - $69.67 $2.17 Million - $3.57 Million	51,200	51,200 $3.57 Million

Others Institutions Holding BPMC

# of Institutions

352

Shares Held

60.7M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $6.83B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Blueprint Medicines Corp Transaction History